Predict your next investment

Xollent Biotech company logo
HEALTHCARE | Biotechnology

See what CB Insights has to offer

Stage

Unattributed | Alive

Total Raised

$50K

Last Raised

$50K | 3 yrs ago

About Xollent Biotech

Xollent Bio develops novel therapeutics for cardiovascular diseases and regeneration medicines. Its target audience includes scientists and venture capitalists.

Xollent Biotech Headquarter Location

621 Hutton Street Suite 104

Raleigh, North Carolina, 27606,

United States

919-513-6157

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Xollent Biotech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Xollent Biotech is included in 1 Expert Collection, including Regenerative Medicine.

R

Regenerative Medicine

1,708 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.